✦ LIBER ✦

Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells

✍ Scribed by Jinxia Zhao; Ru Li; Jing He; Jinxia Shi; Li Long; Zhanguo Li

Publisher: Springer
Year: 2008
Tongue: English
Weight: 473 KB
Volume: 29
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-008-0634-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IL-35 is a novel cytokine with therapeut

IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells

✍ Wanda Niedbala; Xiao-qing Wei; Beilei Cai; Axel J Hueber; Bernard P. Leung; Iain 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 1 views

Correction: IL-35 is a novel cytokine wi

Correction: IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells

✍ Wanda Niedbala; Xiao-qing Wei; Beilei Cai; Axel J Hueber; Bernard P. Leung; Iain 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 1 views

Inhibition of adjuvant-induced arthritis

Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope

✍ Berent J. Prakken; Sarah Roord; Peter J. S. Van Kooten; Josée P. A. Wagenaar; Wi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

## Abstract ## Objective To prevent and treat experimental arthritis via nasal administration of an altered peptide ligand (APL) from the major arthritogenic epitope in adjuvant‐induced arthritis (AIA) and to explore the mechanisms involved. ## Methods Peptides were administered nasally before a